Renaissance Technologies’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
+157,505
New +$156K ﹤0.01% 2931
2025
Q4
Sell
-18,700
Closed -$18.4K 3253
2025
Q3
$18.4K Buy
+18,700
New +$16.9K ﹤0.01% 3431
2024
Q2
Sell
-10,221
Closed -$16K 3501
2024
Q1
$16K Buy
+10,221
New +$14.2K ﹤0.01% 3604
2023
Q3
Sell
-2,522
Closed -$26K 3671
2023
Q2
$26K Buy
2,522
+735
+41% +$7.8K ﹤0.01% 3728
2023
Q1
$22K Buy
1,787
+790
+79% +$12.3K ﹤0.01% 3807
2022
Q4
$18K Buy
997
+300
+43% +$6.13K ﹤0.01% 3977
2022
Q3
$15K Buy
+697
New +$19K ﹤0.01% 3926

Other funds holding BFRI

Renaissance Technologies's BFRI Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Biofrontera (BFRI) in Q2 2026: 157,505 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #2931 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in BFRI as recently as Q3 2025.

Renaissance Technologies first reported a position in BFRI in Q3 2022 and has held it in 7 quarters since. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Renaissance Technologies held 157,505 shares of Biofrontera worth $149K as of Q2 2026.
  • Biofrontera was a new Renaissance Technologies position in Q2 2026.
  • Biofrontera made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2931 holding.
  • Renaissance Technologies first reported a position in Biofrontera in Q3 2022 and has held it in 7 quarters since.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.